GRISEOFULVIN, ULTRAMICROSIZE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Griseofulvin, Ultramicrosize, and when can generic versions of Griseofulvin, Ultramicrosize launch?
Griseofulvin, Ultramicrosize is a drug marketed by Mountain and Sandoz and is included in two NDAs.
The generic ingredient in GRISEOFULVIN, ULTRAMICROSIZE is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Griseofulvin, Ultramicrosize
A generic version of GRISEOFULVIN, ULTRAMICROSIZE was approved as griseofulvin, ultramicrosize by MOUNTAIN on January 9th, 2014.
Summary for GRISEOFULVIN, ULTRAMICROSIZE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 4,390 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GRISEOFULVIN, ULTRAMICROSIZE at DailyMed |
Pharmacology for GRISEOFULVIN, ULTRAMICROSIZE
Drug Class | Tubulin Inhibiting Agent |
Physiological Effect | Decreased Mitosis Microtubule Inhibition |